Retinal tele-screening with digital imaging and manual grading of images may be considered medically necessary as a screening technique for the detection of diabetic retinopathy.
Digital retinal imaging with image interpretation by artificial intelligence software that is approved by the U.S. Food and Drug Administration (eg, IDX-DR, EyeArt) may be considered medically necessary for screening for diabetic retinopathy.
Retinal tele-screening is considered investigational for all other indications, including the monitoring and management of disease in individuals diagnosed with diabetic retinopathy.
